In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
José David CeldránBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0001-5058-9755 Lawrence HumphreysBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0003-1366-1396 Maria Jose VerdúBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.
Desirée GonzálezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.
Cristina Soto-SánchezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0003-4447-5967 Gema Martínez-NavarreteBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0002-9795-2846 Lucía EnríquezNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9072-5245 Iván MaldonadoNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4119-8514 Idoia GallegoNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9312-8147 Mohamed MashalNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-5373-7178 Noha AttiaNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-2618-3891 Gustavo PurasNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-1536-7601 José Luis PedrazNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-3938-2267 Eduardo FernándezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0002-7052-6011 Funding
Horizon 2020 No. 899287 (NeuraViPeR)Ministerio de Ciencia, Innovación y Universidades DTS19/00175Ministerio de Ciencia, Innovación y Universidades PDC2022-133952-100Ministerio de Ciencia, Innovación y Universidades PID2019-106199RB-C21Ministerio de Ciencia, Innovación y Universidades PRE2019-087693Ministerio de Ciencia, Innovación y Universidades PRE 202210042Ministerio de Ciencia, Innovación y Universidades RTI2018-098969-B-I00
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
lipid nanoparticleslipofectamineneuron deliveryoptogenetics
Identifiers
PMID41599112
PMCPMC12845084
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390